OTI-SOL DIN 02436280
Health Canada record
| Active ingredient(s) | ALUMINUM ACETATE 0.5 %; BENZETHONIUM CHLORIDE 0.03 % |
|---|---|
| Dosage form | Solution |
| Route | Otic |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | |
| Current status date | 09-Jan-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALUMINUM ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00674222 | BURO-SOL OTIC SOLUTION | GLAXOSMITHKLINE INC | Solution | ALUMINUM ACETATE 0.5 %; BENZETHONIUM CHLORIDE 0.03 % | Cancelled Post Market |
| 00852341 | STAR-OTIC SOLUTION | STELLAR PHARMACAL CORP | Solution | ALUMINUM ACETATE 10 %; ACETIC ACID 1.5 % | Cancelled Post Market |